BARTOLI FRANCESCO

Position:
Direttore di Scuola di Specializzazione (Universita' di Milano Bicocca)
Role
Associate professor  
Academic disciplines
Psychiatry (MEDS-11/A)
Scientific-Disciplinary Group:
PSYCHIATRY (06/MEDS-11)
Email
[email protected]

Biography

Francesco Bartoli (FB), MD, PhD, is an Associate Professor of Psychiatry at the University of Milano-Bicocca, where he is the Director of the Specialization School in Psychiatry. He is the author of over 150 studies published in international journals indexed in PubMed, Scopus, and Web of Science. His main research interests are in bipolar and affective disorders. FB is the Editor-in-Chief of Alpha Psychiatry and the Deputy Editor of Psychiatry Research Case Reports. He is also an Academic Editor of Depression and Anxiety and Perspectives in Psychiatric Care, as well as an Associate Editor of BMC Psychiatry and Frontiers in Psychiatry. FB is the Principal Investigator of the "ReDREAM" (Resistant Depression Response to Esketamine Assessing Metabolomics) Project, funded by the Ministry of University and Research (MUR) as a Research Project of National Relevance (PRIN 2022 call).

Publications

  • Bartoli, F., Cavaleri, D., Callovini, T., Palpella, D., Piacenti, S., Crocamo, C., et al. (2025). Clinical and metabolic correlates of DSM-5 mixed features in subjects with bipolar depression and mania: A cross-sectional study. JOURNAL OF PSYCHOSOMATIC RESEARCH, 188(January 2025) [10.1016/j.jpsychores.2024.111990]. Detail

  • Crocamo, C., Canestro, A., Palpella, D., Cioni, R., Nasti, C., Piacenti, S., et al. (2024). Digital biomarkers of mood states from speech in bipolar disorder. In Proceedings of the 3rd Workshop on Artificial Intelligence for Human-Machine Interaction 2024
    co-located with the 23rd International Conference of the Italian Association for Artificial Intelligence (AIxIA 2024) (pp.1-7). CEUR-WS.     Detail

  • Bartoli, F., Cavaleri, D., Riboldi, I., Crocamo, C., de Filippis, R., Callegher, R., et al. (2024). The Resistant Depression Response to Esketamine Assessing Metabolomics (ReDREAM) Project- Untargeted Metabolomics to Identify Biomarkers of Treatment Response to Intranasal Esketamine in Individuals with Treatment-Resistant Depression: A Study Protocol. ALPHA PSYCHIATRY, 25(4), 555-560 [10.5152/alphapsychiatry.2024.241549]. Detail

  • Bartoli, F., Bassetti, C., Gazzola, M., Gianfelice, L., Cavaleri, D., Crocamo, C., et al. (2024). Prevalence and correlates of manic/hypomanic and depressive predominant polarity in bipolar disorder: Systematic review and meta-analysis. BJPSYCH OPEN, 10(3) [10.1192/bjo.2024.51]. Detail

  • Bartoli, F., Calabrese, A., Moretti, F., Castiglioni, M., Prestifilippo, L., De Pietra, A., et al. (2024). Exploring depression in people with schizophrenia spectrum disorders: A cross-sectional analysis of the clinical relationship with Positive and Negative Syndrome Scale dimensions. REVISTA BRASILEIRA DE PSIQUIATRIA, 46, e20233418 [10.47626/1516-4446-2023-3418]. Detail

Full list

Research projects

PNRR per la Missione 4, componente 2 Investimento 1.1- Avviso 104/2022 | ReDREAM (Resistant Depression Response to Esketamine Assessing Metabolomics) Project: Untargeted metabolomics to identify biomarkers of treatment response to intranasal esketamine in individuals with Treatment-Resistant Depression
Year: 2022
Call: Bando PRIN 2022
Grantors: MINISTERO DELL'UNIVERSITA' E DELLA RICERCA (MUR)
PRIN 2022 PNRR- Missione 4, Componente 2, Investimento 1.1 -Avviso 1409/22 - DISCARD (DISContination of Antidepressants in Remitted Depression)
Year: 2022
Call: Bando PRIN 2022
Grantors: M.I.U.R. - MINISTERO DELL'ISTRUZIONE, DELL'UNIVERSITA' E DELLA RICERCA

Awards

Awards

  • Stanford 2% top scientist, Stanford University, 2024
  • Brain Sciences Young Investigator Award 2020, MDPI, 2021
  • Publons Academy Mentor 2020, Web of Science - Publons, 2020
  • Web of Science - Publons Peer Review Award 2019, Web of Science - Publons, 2019
  • Publons Peer Review Award 2018, Publons, 2018
  • Publons Peer Review Award 2017, Publons, 2017

Editorial boards

  • Membro del Comitato Editoriale - THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2024
  • Direttore di rivista, collana editoriale, enciclopedia - PSYCHIATRY RESEARCH. CASE REPORTS, 2024
  • Membro del Comitato Editoriale - DEPRESSION AND ANXIETY, 2023
  • Direttore di rivista, collana editoriale, enciclopedia - ALPHA PSYCHIATRY, 2023
  • Associate Editor di rivista o collana editoriale - PSYCHIATRY RESEARCH. CASE REPORTS, 2023 - 2024
  • Associate Editor di rivista o collana editoriale - FRONTIERS IN PSYCHIATRY, 2022
  • Membro del Comitato Editoriale - PERSPECTIVES IN PSYCHIATRIC CARE, 2022
  • Membro del Comitato Editoriale - ALPHA PSYCHIATRY, 2021 - 2023
  • Guest Editor di rivista o collana editoriale - BRAIN SCIENCES, 2020 - 2021
  • Membro del Comitato Editoriale - BMC PSYCHIATRY, 2020
  • Altro tipo di attività editoriale - INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019 - 2021

Research and teaching assignments

  • Ricercatore universitario a t.d. - Università degli Studi di MILANO-BICOCCA, 2021 - 2024
  • Ricercatore universitario a t.d. - Università degli Studi di MILANO-BICOCCA, 2020 - 2021
  • Ricercatore universitario a t.d. - Università degli Studi di MILANO-BICOCCA, 2024

Congresses/Conferences

  • Program committee - Le vite delle persone con schizofrenia in una metropoli: Socialità e benessere per una comunità in rete(Italia), 2022
  • Program committee - Dipendenze e Disturbi Mentali Gravi: le nuove comorbilità tra clinica ed organizzazione dei Servizi(Italia), 2013
  • Program committee - Disturbi mentali gravi e famiglie(Italia), 2011
  • Program committee - Pazienti autori di reato, DSM e interventi terapeutico-riabilitativi(Italia), 2011
  • Partecipazione al comitato organizzativo - XII Congresso dell'International Society of Addiction Medicine (ISAM) "Bridging the Gap between Science and Practice in the Addiction Medicine Field"(Italia), 2010